tiprankstipranks
ARYx Therapeutics Inc (ARYX)
OTHER OTC:ARYX
US Market

ARYx Therapeutics (ARYX) Income Statement

4 Followers

ARYx Therapeutics Income Statement

Last quarter (Q ), ARYx Therapeutics's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q, ARYx Therapeutics's net income was $-1.05M. See ARYx Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 135.52M$ 298.40M$ 62.52M$ 40.57M$ 120.28M$ 160.83M
Cost of Revenue
$ -106.14M$ 243.42M$ 63.93M$ -50.76M$ -128.02M$ -156.81M
Gross Profit
$ 29.37M$ 54.98M$ -1.40M$ -10.19M$ -7.75M$ 4.02M
Operating Expense
$ -18.82M$ 32.98M$ 9.81M$ -9.85M$ -16.65M$ -18.18M
Operating Income
$ 8.33M$ 22.00M$ -11.21M$ -20.04M$ -24.40M$ -14.16M
Net Non Operating Interest Income Expense
$ -2.13M$ -6.07M$ 990.00K$ 1.21M$ 1.60M$ 443.00K
Other Income Expense
$ 5.67M$ -13.49M$ 3.57M$ 4.17M$ -7.29M$ -8.46M
Pretax Income
$ 5.84M$ 22.96M$ -8.63M$ -25.42M$ -18.72M$ -6.14M
Tax Provision
$ -17.33M$ 4.61M-$ -2.31M$ -470.00K$ -10.92M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 6.51M$ 18.35M$ -8.63M$ -27.73M$ -19.19M$ -17.06M
Basic EPS
$ -0.46$ 0.11$ -0.13$ -0.56$ -0.39$ -0.34
Diluted EPS
$ -0.46$ 0.11$ -0.13$ -0.56$ -0.39$ -0.34
Basic Average Shares
$ 337.22M$ 162.55M$ 65.03M$ 49.47M$ 49.47M$ 49.45M
Diluted Average Shares
$ 341.99M$ 166.13M$ 65.74M$ 49.47M$ 49.52M$ 49.55M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ -124.96M$ 276.40M----
Net Income From Continuing And Discontinued Operation
$ 6.51M$ 18.35M$ -8.63M$ -27.73M$ -19.19M$ -17.06M
Normalized Income
$ 3.60M-$ -8.63M$ 648.13M$ 477.28M$ 156.54M
Interest Expense
------
EBIT
$ 7.97M$ 29.04M$ -7.64M$ -26.63M$ -20.32M$ -6.58M
EBITDA
$ 16.16M--$ -26.05M$ -19.16M$ -6.38M
Currency in USD

ARYx Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis